MX2024007862A - Una composicion farmaceutica inyectable para el tratamiento de enfermedades respiratorias en animales. - Google Patents
Una composicion farmaceutica inyectable para el tratamiento de enfermedades respiratorias en animales.Info
- Publication number
- MX2024007862A MX2024007862A MX2024007862A MX2024007862A MX2024007862A MX 2024007862 A MX2024007862 A MX 2024007862A MX 2024007862 A MX2024007862 A MX 2024007862A MX 2024007862 A MX2024007862 A MX 2024007862A MX 2024007862 A MX2024007862 A MX 2024007862A
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical composition
- injectable pharmaceutical
- animals
- treatment
- respiratory diseases
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 241001465754 Metazoa Species 0.000 title abstract 2
- 208000023504 respiratory system disease Diseases 0.000 title 1
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21217704 | 2021-12-24 | ||
| PCT/EP2022/087700 WO2023118557A1 (en) | 2021-12-24 | 2022-12-23 | An injectable pharmaceutical composition for the treatment of respiratory diseases in animals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024007862A true MX2024007862A (es) | 2024-07-09 |
Family
ID=79601675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024007862A MX2024007862A (es) | 2021-12-24 | 2022-12-23 | Una composicion farmaceutica inyectable para el tratamiento de enfermedades respiratorias en animales. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250057790A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4452226A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024544415A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118632684A (cg-RX-API-DMAC7.html) |
| AR (1) | AR128074A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022420882A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3242451A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024007862A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023118557A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021335500A1 (en) | 2020-09-04 | 2023-05-04 | Elanco Us Inc. | Palatable formulations |
| AR134777A1 (es) | 2023-12-21 | 2026-04-01 | Intervet Int Bv | Formas cristalinas de sales de (s)-n-(3-amino-1-(hidroxiamino)-3-metil-1-oxobutan-2-il)-4-((4-(((2-metoxietil)amino)metil)fenil)etinil)benzamida |
| CN122422289A (zh) | 2023-12-21 | 2026-07-17 | 英特维特国际股份有限公司 | (s)-n-(3-氨基-1-(羟基氨基)-3-甲基-1-氧代丁-2-基)-4-((4-(((2-甲氧基乙基)氨基)甲基)苯基)乙炔基)苯甲酰胺盐的结晶形式的制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3740421A (en) | 1966-09-19 | 1973-06-19 | Basf Wyandotte Corp | Polyoxyethylene-polyoxypropylene aqueous gels |
| JP7082445B2 (ja) | 2016-12-23 | 2022-06-08 | インターベット インターナショナル ベー. フェー. | ウシ又はブタの呼吸器疾患を治療するための化合物 |
-
2022
- 2022-12-22 AR ARP220103558A patent/AR128074A1/es unknown
- 2022-12-23 MX MX2024007862A patent/MX2024007862A/es unknown
- 2022-12-23 CA CA3242451A patent/CA3242451A1/en active Pending
- 2022-12-23 US US18/721,947 patent/US20250057790A1/en active Pending
- 2022-12-23 AU AU2022420882A patent/AU2022420882A1/en active Pending
- 2022-12-23 CN CN202280085114.3A patent/CN118632684A/zh active Pending
- 2022-12-23 JP JP2024537407A patent/JP2024544415A/ja active Pending
- 2022-12-23 EP EP22844124.2A patent/EP4452226A1/en active Pending
- 2022-12-23 WO PCT/EP2022/087700 patent/WO2023118557A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA3242451A1 (en) | 2023-06-29 |
| WO2023118557A1 (en) | 2023-06-29 |
| US20250057790A1 (en) | 2025-02-20 |
| AU2022420882A1 (en) | 2024-06-20 |
| JP2024544415A (ja) | 2024-11-29 |
| EP4452226A1 (en) | 2024-10-30 |
| AR128074A1 (es) | 2024-03-20 |
| CN118632684A (zh) | 2024-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA3242451A1 (en) | An injectable pharmaceutical composition for the treatment of respiratory diseases in animals | |
| MY196455A (en) | Nitrile-Containing Compounds Useful as Antiviral Agents for The Treatment of a Coronavirus Infection | |
| MX2023003564A (es) | Compuestos y su uso en el tratamiento del cancer. | |
| PH12020550107A1 (en) | Chromane monobactam compounds for the treatment of bacterial infections | |
| MX2023005983A (es) | Nuevos agentes antivirales derivados de la espiropirrolidina. | |
| MX2022011804A (es) | Uso de agentes para el tratamiento de condiciones respiratorias. | |
| BRPI0618374A2 (pt) | uso de um composto ou um derivado do mesmo farmaceuticamente aceitável, métodos para matar microorganismos clinicamente latentes em um mamìfero, para tratar ou prevenir uma infecção microbiana em um mamìfero, para esterilizar um objeto, para preservar um material inorgánico ou orgánico, para tratar uma doença, para reduzir a dose de agente antimicrobiano convencional requerida para tratar uma infecção microbiana e para tratar uma doença de protozoário em um mamìfero, produto combinado, formulação, uso de um produto combinado, composto, e, processo para a preparação do mesmo | |
| TW200600492A (en) | Substituted aryl acylthioureas and related compounds; inhibitors of viral replication | |
| NZ591525A (en) | Methods of treatment of complicated skin and skin structure infections using single doses of oritavancin | |
| RU2414902C1 (ru) | Бактерицидная композиция для профилактики и лечения инфекционных заболеваний копыт у животных | |
| AU2021311245A8 (en) | Compound for androgen receptor degradation, and pharmaceutical use thereof | |
| AR060089A1 (es) | Tratamiento del dolor | |
| PH12022552166A1 (en) | Use of compound in preventing and/or treating pathogen infection in animals | |
| BR112021025764A2 (pt) | Derivado de pirimidina que inibe o crescimento de células cancerígenas e uso medicinal do mesmo | |
| MX2022006742A (es) | Uso y composicion farmaceutica de derivados de fenilisoxazolil metilen-naftaleno-eter. | |
| Adegbeye et al. | Potential of silver nanoparticles for veterinary applications in livestock performance and health | |
| WO2020201833A8 (en) | Gepotidacin for use in the treatment of bacterial urinary tract infections | |
| MX2025005318A (es) | Compuesto de cucurbiturilo y uso medico del mismo | |
| MY170991A (en) | Dosing regimens of celgosivir for the treatment of dengue | |
| UA49789C2 (uk) | Застосування димеру лізоциму як лікарського засобу для інгібування біосинтезу фактора некрозу пухлини, спосіб лікування та профілактики захворювань (варіанти), фармацевтична композиція (варіанти), застосування димеру лізоциму як лікарського засобу для профілактики або лікування сніду | |
| EA202193211A1 (ru) | Лечение синуклеопатий | |
| NZ769696A (en) | Endoparasitic depsipeptides | |
| BRPI0410576A (pt) | composto quìmico, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, método para o tratamento, prevenção ou alìvio de uma doença ou um distúrbio ou condição de um corpo de animal vivo | |
| PT1059845E (pt) | Composicao fungicida compreendendo uma benzoilfenilureia | |
| UA144735U (uk) | Спосіб лікування хвороб органів травлення |